GSK, Vir enter Phase 3 clinical trials for Covid-19 drug VIR-7831
The phase 3 COMET-ICE trial will evaluate the safety and efficacy of a single intravenous infusion of VIR-7831…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Oct 20
The phase 3 COMET-ICE trial will evaluate the safety and efficacy of a single intravenous infusion of VIR-7831…
25 Sep 20
The late-stage clinical trial is designed to enrol up to 10,000 volunteers across the UK to evaluate the…
24 Sep 20
Phase 3 ENSEMBLE study is designed to enrol up to 60,000 adult volunteers to evaluate the safety and…
14 Sep 20
The UK committee has resolved its investigations and recommended the MHRA that Covid-19 vaccine trials in the UK…
11 Sep 20
ENSPRYNG was recently approved by the US Food and Drug Administration (FDA) for adults with anti-aquaporin-4 (AQP4) antibody…
09 Sep 20
The UK-based drugmaker has voluntarily paused the clinical trials to ensure the review of safety data by an…
08 Sep 20
The clinical trial in Germany will evaluate the safety and efficacy of potential Covid-19 vaccine candidate BNT162b2 in…
04 Sep 20
Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing…
03 Sep 20
Janssen’s decision is based on results from the interim analyses of the Phase 3 clinical study of Pimodivir…
01 Sep 20
The Phase III D8110C00001 trial will evaluate the safety, efficacy and immunogenicity of the AZD1222 vaccine in up…